The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 has updated some existing terminology and introduced some new terms.
From 28 April 2026, our existing guidance, processes, systems and model agreements have been updated to make sure that the terminology we use matches the updated terminology in the legislation where appropriate.
This guidance provides more information about the changes: